There are several OTC therapies available to combat allergic conjunctivitis. The topical ophthalmic H1 antihistamines have a more rapid onset of action than oral H1 antihistamines but require more ...

Allergic conjunctivitis and ocular allergy comprise a spectrum of immune-mediated disorders that primarily affect the ocular surface, resulting in symptoms such as itching, redness, tearing and, in ...

Pink eye can be caused by allergies or an infection. Prostock-Studio/Getty Images Pink eye is a catch-all term for multiple kinds of conjunctivitis that may be caused by irritants, viruses, bacteria, ...

Allergic conjunctivitis can result in eye inflammation caused by an allergic reaction to mold or pollen spores, but several treatments are available to decrease and alleviate symptoms. Patients who ...

Allergic conjunctivitis harms quality of life for children and their parents, apparently causing greater day-to-day worries than potentially blinding diseases, researchers report. Parents worry ...

Please provide your email address to receive an email when new articles are posted on . Dextenza may relieve ocular itching in patients with allergic conjunctivitis for up to 4 weeks, according to a ...

In allergic conjunctivitis, these symptoms are usually present in both eyes (not always equally). See your ophthalmologist (a doctor and surgeon who is trained to treat eye conditions), optometrist ...

Eyevance announced the launch of Zerviate™ (cetirizine ophthalmic solution) 0.24% for the treatment of ocular itching associated with allergic conjunctivitis in patients 2 years of age and older.

Aldeyra Therapeutics reported positive results from a Phase III study of Reproxalap, an eye drop drug for allergic conjunctivitis and dry eye disease that provides immediate relief to patients. The ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to ...